kabutan

ASKA Pharmaceutical Holdings Co.,Ltd.(4886) Summary

4886
TSE Prime
ASKA Pharmaceutical Holdings Co.,Ltd.
1,930
JPY
-15
(-0.77%)
Dec 12, 3:30 pm JST
12.38
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
1,940.7
Dec 12, 11:17 pm JST
Summary Chart Historical News Financial Result
PER
10.9
PBR
0.82
Yield
2.85%
Margin Trading Ratio
14.39
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
1,984 JPY 12.75 USD
Previous Close Dec 11
1,945 JPY 12.46 USD
High Dec 12, 9:00 am
1,984 JPY 12.75 USD
Low Dec 12, 1:52 pm
1,922 JPY 12.34 USD
Volume
74,700
Trading Value
0.15B JPY 0.93M USD
VWAP
1946.64 JPY 12.49 USD
Minimum Trading Value
193,000 JPY 1,238 USD
Market Cap
0.06T JPY 0.36B USD
Number of Trades
252
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Mid
1-Year Average
247
1-Year High Sep 1, 2025
3,060
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 14,300 133,300 9.32
Nov 28, 2025 12,700 122,200 9.62
Nov 21, 2025 9,600 122,800 12.79
Nov 14, 2025 11,500 134,400 11.69
Nov 7, 2025 23,800 134,800 5.66
Company Profile
ASKA Pharmaceutical Holdings Co., Ltd. specializes in gynecology and urology, with hormone preparations as its main products. The company sells generic drugs for Takeda and also develops new drugs.
Sector
Pharmaceuticals
ASKA Pharmaceutical Holdings Co., Ltd. focuses on the pharmaceutical business as its core, while also operating in animal health and clinical testing sectors. In the pharmaceutical business, "Aska Pharmaceutical" specializes in products for internal medicine, obstetrics and gynecology, and urology, which are distributed through Takeda Pharmaceutical Company. The animal health business is managed by "Aska Animal Health," which procures some products from Aska Pharmaceutical while also outsourcing manufacturing to Aska Pharmaceutical. The clinical testing business is operated by "Aska Pharmaceutical Medical," which leases facilities from Aska Pharmaceutical for its operations. Additionally, Aska Pharmaceutical handles the procurement and sales of medical devices and health foods. The company has adopted a holding company structure to manage its group companies effectively.